Key Topics of the Forum
Turkic States Cooperation in Healthcare and Pharmaceuticals
- Joint priorities in healthcare development within the Organisation of Turkic States
- Harmonisation of regulatory frameworks and potential mutual recognition of clinical trials
- Strengthening collaboration in pharmaceutical manufacturing, quality standards, and logistics
- Shared approaches to disease prevention, digital health, and emergency preparedness
- Opportunities for creating joint programmes in innovation, training, and technology transfer
Medicines
- Medicine pricing: regulation, affordability, and the impact on business
- Introduction of VAT on medicines: risks, cost implications, and system sustainability
- Public Procurement 2.0: balancing price and quality, innovation, and transparency
- Re-registration under EAEU rules: deadlines, risks, and market implications
- Composite service: integrating expertise, registration, and pricing in a single process
- Provision of medicines for orphan patients: funding, procurement, and long-term sustainability
- Co-payment: pilot project and the first steps towards a new model of medicine provision
- Strategic priorities of pharmaceutical companies in a changing economic environment
- The future of generics and innovative medicines
- Local manufacturing: export potential, investment, and development barriers
- Consolidation and reshaping of the pharmacy market: who stands to win and who may lose
- Medicine labelling: implementation errors, data use, analytics, and confidentiality